The American Cancer Society assembled leading researchers in Phoenix this week for an exchange of progress reports. Among the significant findings: > Though scarce and "very costly," said Yale University's Dr. Robert E. Handschumacher, a new drug shows unique promise in relieving the crises of adult patients suffering from some forms of acute leukemia. Earlier anti-leukemic drugs worked mostly in children and were almost as poisonous to the patient as to his cancerous cells. But 6-azauridine, which has to be injected, and a still newer chemical variant that can be taken by...
To continue reading:
or
Log-In